Darolutamide for patients with androgen receptor positive salivary gland cancers (DISCOVARY): The results of phase 2 study of darolutamide monotherapy-MedSci.cn

Darolutamide for patients with androgen receptor positive salivary gland cancers (DISCOVARY): The results of phase 2 study of darolutamide monotherapy

Okano, S; Tahara, M; Imamura, Y; Uryu, H; Otsuka, T; Ohkoshi, A; Sano, D; Tsukahara, K; Ono, K; Hanazawa, T; Kano, S; Nishio, N; Nagaoka, M; Kiyota, N

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (16):

科室
- - 订阅+
  - 更多科室
工具
服务